Clinical Trials for Meridigen Biotech

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Meridigen Biotech

Clinical Trials (3)

NCT04347967
Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS)
PHASE1Not yet recruiting
18 participants
Started: Jan 1, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT04097652
Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke
PHASE1Recruiting
9 participants
Started: Dec 5, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03631420
Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants
PHASE1Recruiting
9 participants
Started: Oct 26, 2018 · Completed: Jul 31, 2027
1 condition1 sponsor1 location